Clinical Trials Browser

Carcinoma × cabozantinib × 90 days × Clear all

NCT05136196 2026-06-05

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Melanoma, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT07227402 2026-06-04

LITESPARK-033

Phase 3 Recruiting

904 enrolled

Genitourinary

Carcinoma, Carcinoma, Renal Cell